COSMOS HEALTH INC.
Last · NASDAQ$0.2693+0.0153 (+6.02%)close · yahoo · 7h ago
Market cap$27.10M100.6M sh
P/E · TTM-0.4fwd 3.8 · eps -0.67 · loss
Beta4.17vs S&P 500
Div yield—annual · TTM
52w range
$0.162$1.32
Volume2.5Msession
| Revenue | $65.3M |
|---|---|
| Operating income | $-16.7M |
| Net income | $-19.1M |
| Free cash flow | $-8.5M |
| Operating margin | -25.6% |
| Net margin | -29.3% |
| Return on equity | -103.9% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-04-15
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Cash Runway Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -29.3%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -12.9%
- Cash Runway Low — Cash runway ~0.1 years
- Accumulated Deficit High — Accumulated deficit / equity 723%
Press & signals
- GlobeNewswire
Cosmos Health: A Company Transformed — 2026 Year-to-Date
- GlobeNewswire
Cosmos Health Enters Saudi Arabia Through Exclusive Distribution Agreement With Innova Healthcare; Secures Initial Purchase Order of 126,000 Sky Premium Life Units, With More Than 5 Million Units Expected Over Initial 5-Year Term
- GlobeNewswire
Cosmos Health Reports Q2 2026 Results: Record Q2 and H1 Revenue of $19.0M and $36.9M, Up 29% and 30%; Q2 Adjusted Gross Profit Up 58%; Total Liabilities Reduced 13%; Stockholders' Equity Up 12%; $5M Share Repurchase Program Underway
The rest of this company's wire — with summaries and source links — is part of Pro.
See plans